Lung Cancer
Approximately 13% of lung cancer patients have small cell lung cancer (SCLC), and chemotherapy is the primary treatment for this form of cancer. Patients who are diagnosed with non-small cell lung cancer at an earlier stage typically undertake surgery to combat the disease. In contrast, approximately 63% of patients with stage 3 non-small cell lung cancer are treated with chemotherapy and radiation. Chemotherapy contributes nearly 19% to the five-year survival rate among all stages of lung cancer patients. The five-year survival rate for non-small cell lung cancer is 23%, whereas it is only 6% for small cell lung cancer. Chemotherapy is quite effective at killing cancer cells and offers lung cancer patients a 57% greater chance of complete recovery.
